Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEOGENOMICS INCNEO · Entity 2096 | Director | November 16, 2020 | November 18, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEOGENOMICS INC
Report date November 16, 2020 · Filed November 18, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 66,800 |
Reported balance
After 2020-11-16 transaction · row 1
1 source rowRow 1 · 2020-11-16 · Sale · Disposed 70,000 · Balance 66,800 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.27 · Expires 2022-05-25 | Direct | 3,334 |
Reported balance
Holding disclosure · report date 2020-11-16 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 3,334 F1: On May 25, 2017, Mr. Hipp was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.52 · Expires 2026-06-06 | Direct | 4,269 |
Reported balance
Holding disclosure · report date 2020-11-16 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 4,269 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.54 · Expires 2027-05-28 | Direct | 3,448 |
Reported balance
Holding disclosure · report date 2020-11-16 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 3,448 |
Filing footnotes · ownership attribution and instrument terms
F1: On May 25, 2017, Mr. Hipp was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 16, 2020 Filed Nov 18, 2020 23:53 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 70,000 | $42.28 | $2,959,600.00 |
DisclosureSEC source: 0001077183-20-000213 · wf-form4_160574356403275.xml · nonDerivative · entry 1 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,800 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 22:57 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantStock Options (Right to Buy) · Derivative | 3,448 | $0.00 Strike: $28.54 | $0.00 |
DisclosureSEC source: 0001077183-20-000132 · wf-form4_159105221595007.xml · derivative · entry 4 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,448 Underlying: Common Stock · 3,448 shares Expires 2027-05-28 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 22:57 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 2,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000132 · wf-form4_159105221595007.xml · nonDerivative · entry 1 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,800 Read SEC document |
| August 26, 2019 Filed Aug 27, 2019 21:44 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 15,424 | $24.79 | $382,360.96 |
DisclosureSEC source: 0001077183-19-000156 · wf-form4_156694223006156.xml · nonDerivative · entry 5 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,102 Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:44 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,017 | $0.00 Strike: $11.60 | $0.00 |
DisclosureSEC source: 0001077183-19-000156 · wf-form4_156694223006156.xml · derivative · entry 8 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,017 shares Expires 2023-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:44 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,333 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001077183-19-000156 · wf-form4_156694223006156.xml · derivative · entry 7 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,334 Underlying: Common Stock · 6,667 shares Expires 2022-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On May 25, 2017, Mr. Hipp was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:44 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,777 | $0.00 Strike: $9.11 | $0.00 |
DisclosureSEC source: 0001077183-19-000156 · wf-form4_156694223006156.xml · derivative · entry 6 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,777 shares Expires 2021-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On July 28, 2016, Mr. Hipp was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:44 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 600 | $25.02 | $15,012.00 |
DisclosureSEC source: 0001077183-19-000156 · wf-form4_156694223006156.xml · nonDerivative · entry 4 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,526 Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:44 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 2,777 | $9.11 | $25,298.47 |
DisclosureSEC source: 0001077183-19-000156 · wf-form4_156694223006156.xml · nonDerivative · entry 3 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:44 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 3,333 | $7.27 | $24,230.91 |
DisclosureSEC source: 0001077183-19-000156 · wf-form4_156694223006156.xml · nonDerivative · entry 2 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:44 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 3,017 | $11.60 | $34,997.20 |
DisclosureSEC source: 0001077183-19-000156 · wf-form4_156694223006156.xml · nonDerivative · entry 1 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2019 Filed Jun 11, 2019 01:14 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantStock Option (Right to Buy) · Derivative | 4,269 | $0.00 Strike: $22.52 | $0.00 |
DisclosureSEC source: 0001077183-19-000107 · wf-form4_156021567984441.xml · derivative · entry 5 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,269 Underlying: Common Stock · 4,269 shares Expires 2026-06-06 Read SEC document |
| June 06, 2019 Filed Jun 11, 2019 01:14 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 3,419 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-19-000107 · wf-form4_156021567984441.xml · nonDerivative · entry 1 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,999 Read SEC document |
| May 08, 2019 Filed May 10, 2019 01:55 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 118,479 | $22.36 | $2,649,190.44 |
DisclosureSEC source: 0001077183-19-000070 · wf-form4_155745332576193.xml · nonDerivative · entry 2 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,580 Read SEC document |
| May 07, 2019 Filed May 10, 2019 01:55 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 31,521 | $22.61 | $712,689.81 |
DisclosureSEC source: 0001077183-19-000070 · wf-form4_155745332576193.xml · nonDerivative · entry 1 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,059 Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:57 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,333 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001077183-19-000013 · wf-form4_155139102644751.xml · derivative · entry 7 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 Underlying: Common Stock · 3,333 shares Expires 2022-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On May 25, 2017, Mr. Hipp was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:57 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,556 | $0.00 Strike: $9.11 | $0.00 |
DisclosureSEC source: 0001077183-19-000013 · wf-form4_155139102644751.xml · derivative · entry 6 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,777 Underlying: Common Stock · 5,556 shares Expires 2021-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On July 28, 2016, Mr. Hipp was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:57 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.78 | $0.00 |
DisclosureSEC source: 0001077183-19-000013 · wf-form4_155139102644751.xml · derivative · entry 5 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On May 6, 2015, Mr. Hipp was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:57 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 18,889 | $18.90 | $357,002.10 |
DisclosureSEC source: 0001077183-19-000013 · wf-form4_155139102644751.xml · nonDerivative · entry 4 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,580 Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:57 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 3,333 | $7.27 | $24,230.91 |
DisclosureSEC source: 0001077183-19-000013 · wf-form4_155139102644751.xml · nonDerivative · entry 3 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:57 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 5,556 | $9.11 | $50,615.16 |
DisclosureSEC source: 0001077183-19-000013 · wf-form4_155139102644751.xml · nonDerivative · entry 2 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:57 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 10,000 | $4.78 | $47,800.00 |
DisclosureSEC source: 0001077183-19-000013 · wf-form4_155139102644751.xml · nonDerivative · entry 1 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:36 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantStock Option (Right to Buy) · Derivative | 3,017 | $0.00 Strike: $11.60 | $0.00 |
DisclosureSEC source: 0001077183-18-000040 · wf-form4_152823456498053.xml · derivative · entry 2 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,017 Underlying: Common Stock · 3,017 shares Expires 2023-06-01 Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:36 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 15,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000040 · wf-form4_152823456498053.xml · nonDerivative · entry 1 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,580 Read SEC document |
| May 30, 2017 Filed May 31, 2017 01:36 UTC | NEOGENOMICS INC NEO · Entity 2096 | ConversionRestricted Stock · Derivative | 5,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036320 · doc4.xml · derivative · entry 4 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,072 shares Expires 2017-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. F2 · kind: Restricted stock has vested and restricted stock certificate issued for shares of the company's common stock. F4 · derivative.exercise_date: 1,690.6 shares will vest on September 30, 2016 and thereafter, 1,690.7 shares will vest on the last day of each calendar quarter for the next two fiscal quarters up to March 31, 2017. Read SEC document |
| May 30, 2017 Filed May 31, 2017 01:36 UTC | NEOGENOMICS INC NEO · Entity 2096 | ConversionRestricted Stock · Derivative | 2,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036320 · doc4.xml · derivative · entry 3 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,150 shares Expires 2017-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. F2 · kind: Restricted stock has vested and restricted stock certificate issued for shares of the company's common stock. F3 · derivative.exercise_date: 537.5 shares will vest on June 30, 2016 and thereafter, 537.5 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2017. Read SEC document |
| May 30, 2017 Filed May 31, 2017 01:36 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 7,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036320 · doc4.xml · nonDerivative · entry 2 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2017 Filed May 31, 2017 01:36 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantRestricted Stock · Derivative | 8,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036320 · doc4.xml · derivative · entry 8 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,667 Underlying: Common Stock · 8,667 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. F8 · derivative.exercise_date: The restricted stock will vest as follows; 2,166 units at June 30, 2017 and thereafter, 2,167 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2018. F9 · derivative.expiration_date: These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date. Read SEC document |
| May 25, 2017 Filed May 31, 2017 01:36 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $7.27 Strike: $7.27 | $72,700.00 |
DisclosureSEC source: 0001209191-17-036320 · doc4.xml · derivative · entry 7 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2022-05-25 F7 · derivative.exercise_date: On May 25, 2017, Mr. Hipp was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.